Montelukast Prescribing at THE CHISLEHURST PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
638
Total Quantity
31.4K
NHS Cost
£2.0K
vs National Avg
-6.8%
THE CHISLEHURST PARTNERSHIP prescribed 638 items of Montelukast over the last 12 months at a cost of £1,976 to the NHS. This is 6.8% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
57
Jul 2026
63
Jul 2026
71
Jul 2026
52
Jul 2026
39
Jul 2026
57
Jul 2026
54
Jul 2026
48
Jul 2026
64
Jul 2026
43
Jul 2026
48
Jul 2026
42
Prescribing Details
| Total Items | 638 |
|---|---|
| Total Quantity | 31,419 |
| Total NHS Cost | £1,976 |
| Presentations | 5 different forms |
| vs National Average | -6.8% |
Montelukast Prescribing Comparison
| This practice | 638 items |
|---|---|
| National average per practice | 685 items |
| Difference | -6.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.